{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T18:31:40Z","timestamp":1786818700161,"version":"build-2736575974"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2012,6]]},"abstract":"<jats:sec>\n            <jats:title>Purpose of review<\/jats:title>\n            <jats:p>Cases of de-novo autoimmune hepatitis\/plasma cell hepatitis (PCH) are increasingly being diagnosed by liver transplant centers. Its pathogenesis is poorly understood but this entity appears to be a variant of rejection. Herein, we review recent clinical reports of patients developing PCH.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Recent findings<\/jats:title>\n            <jats:p>Histologically, PCH is a challenging diagnosis, especially in the setting of recurrent hepatitis C and, in some cases, can be mistaken for acute cellular rejection. Recent case reports and case\u2013control studies have shown that interferon appears to trigger PCH in hepatitis C posttransplant patients. Optimization of the immunosuppression regimen was found to prevent the development of PCH. In the nonhepatitis C posttransplant patient, tacrolimus-based immunosuppression appears to have some protective effect from PCH development. A combination therapy of cyclosporine and everolimus has also been shown to be effective in treating PCH.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Summary<\/jats:title>\n            <jats:p>PCH is a variant of rejection and is a cause of late graft loss post liver transplantation, especially in patients with hepatitis C. It should be part of the differential diagnosis of abnormal liver enzyme tests occurring in the post-liver transplant setting.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/mot.0b013e3283536622","type":"journal-article","created":{"date-parts":[[2012,4,12]],"date-time":"2012-04-12T13:02:47Z","timestamp":1334235767000},"page":"287-292","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":45,"title":["Plasma cell hepatitis (de-novo autoimmune hepatitis) developing post liver transplantation"],"prefix":"10.1097","volume":"17","author":[{"given":"M. Isabel","family":"Fiel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Schiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-14-20250502","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1055\/s-0031-1272834","article-title":"De novo autoimmune hepatitis after liver transplantation.","volume":"31","author":"Guido","year":"2011","journal-title":"Semin Liver Dis"},{"key":"R3-14-20250502","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1111\/j.1432-2277.2010.01143.x","article-title":"Current views on rejection pathology in liver transplantation.","volume":"23","author":"Neil","year":"2010","journal-title":"Transpl Int"},{"key":"R4-14-20250502","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/lt.21447","article-title":"Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus.","volume":"14","author":"Fiel","year":"2008","journal-title":"Liver Transpl"},{"key":"R6-14-20250502","first-page":"750","article-title":"Plasma cell hepatitis in liver allografts: variant of rejection or autoimmune hepatitis Liver T","volume":"14","author":"Demetris","year":"2008","journal-title":"ranspl"},{"key":"R7-14-20250502","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1399-0012.2010.01221.x","article-title":"Choice of calcineurin inhibitor may influence the development of de novo immune hepatitis associated with anti-GSTT1 antibodies after liver transplantation.","volume":"25","author":"Aguilera","year":"2011","journal-title":"Clin Transplant"},{"key":"R8-14-20250502","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1136\/jcp.2009.068254","article-title":"Liver allograft pathology: approach to interpretation of needle biopsies with clinicopathological correlation.","volume":"63","author":"Adeyi","year":"2010","journal-title":"J Clin Pathol"},{"key":"R10-14-20250502","first-page":"702","article-title":"What is the long-term outcome of the liver allograft J H","volume":"55","author":"Hubscher","year":"2011","journal-title":"epatol"},{"key":"R11-14-20250502","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/hep.21152","article-title":"Progressive histological damage in liver allografts following pediatric liver transplantation.","volume":"43","author":"Evans","year":"2006","journal-title":"Hepatology"},{"issue":"Suppl 3","key":"R12-14-20250502","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.1002\/lt.22413","article-title":"The immunoreactive patient: rejection and autoimmune disease.","volume":"17","author":"OGrady","year":"2011","journal-title":"Liver Transpl"},{"key":"R13-14-20250502","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.clinre.2011.04.009","article-title":"Liver transplantation and hepatitis C.","volume":"35","author":"Rubin","year":"2011","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R14-14-20250502","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1007\/s00595-010-4392-z","article-title":"De novo autoimmune hepatitis subsequent to switching from type 2b to type 2a alpha-pegylated interferon treatment for recurrent hepatitis C after liver transplantation: report of a case.","volume":"41","author":"Takeishi","year":"2011","journal-title":"Surg Today"},{"key":"R15-14-20250502","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1002\/lt.21949","article-title":"Plasma cell hepatitis in hepatitis C virus patients post-liver transplantation: case-control study showing poor outcome and predictive features in the liver explant.","volume":"15","author":"Ward","year":"2009","journal-title":"Liver Transpl"},{"key":"R16-14-20250502","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1399-3046.2005.00470.x","article-title":"Successful treatment of de novo autoimmune hepatitis and cirrhosis after pediatric liver transplantation.","volume":"10","author":"Gibelli","year":"2006","journal-title":"Pediatr Transplant"},{"key":"R17-14-20250502","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.cld.2011.08.008","article-title":"Recurrent and de novo autoimmune liver diseases.","volume":"15","author":"Mendes","year":"2011","journal-title":"Clin Liver Dis"},{"key":"R18-14-20250502","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/j.1600-6143.2006.01717.x","article-title":"Rejection and steroid dependence: unique risk factors in the development of pediatric posttransplant de novo autoimmune hepatitis.","volume":"7","author":"Venick","year":"2007","journal-title":"Am J Transplant"},{"key":"R19-14-20250502","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.1016\/j.transproceed.2005.10.042","article-title":"Glutathione S-transferase T1 genetic mismatch is a risk factor for de novo immune hepatitis in liver transplantation.","volume":"37","author":"Aguilera","year":"2005","journal-title":"Transplant Proc"},{"key":"R20-14-20250502","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/MOG.0b013e3282f57268","article-title":"Autoimmune liver disease.","volume":"24","author":"Czaja","year":"2008","journal-title":"Curr Opin Gastroenterol"},{"key":"R21-14-20250502","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1002\/lt.21108","article-title":"Natural history of unexplained chronic hepatitis after liver transplantation.","volume":"13","author":"Syn","year":"2007","journal-title":"Liver Transpl"},{"key":"R22-14-20250502","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/j.1432-2277.2008.00803.x","article-title":"Idiopathic posttransplantation hepatitis following living donor liver transplantation, and significance of autoantibody titre for outcome.","volume":"22","author":"Miyagawa-Hayashino","year":"2009","journal-title":"Transpl Int"},{"key":"R23-14-20250502","first-page":"237","article-title":"High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis G","volume":"56","author":"Berardi","year":"2007","journal-title":"ut"},{"key":"R24-14-20250502","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.26756","article-title":"Graft dysfunction mimicking autoimmune hepatitis following liver transplantation in adults.","volume":"34","author":"Heneghan","year":"2001","journal-title":"Hepatology"},{"key":"R25-14-20250502","first-page":"345","article-title":"Immune-mediated liver dysfunction after antiviral treatment in liver transplanted patients with hepatitis C: allo or autoimmune de novo hepatitis Dig Liver D","volume":"41","author":"Merli","year":"2009","journal-title":"is"},{"key":"R27-14-20250502","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jhep.2010.11.012","article-title":"Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients.","volume":"55","author":"Selzner","year":"2011","journal-title":"J Hepatol"},{"key":"R28-14-20250502","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S0140-6736(97)06478-7","article-title":"De-novo autoimmune hepatitis after liver transplantation.","volume":"351","author":"Kerkar","year":"1998","journal-title":"Lancet"},{"key":"R30-14-20250502","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1016\/j.transproceed.2011.05.030","article-title":"De novo autoimmune hepatitis in Korean children after liver transplantation: a single institutions experience.","volume":"43","author":"Cho","year":"2011","journal-title":"Transplant Proc"},{"key":"R31-14-20250502","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.transproceed.2008.05.042","article-title":"De novo autoimmune hepatitis following liver transplantation: a case report.","volume":"40","author":"Di Cocco","year":"2008","journal-title":"Transplant Proc"},{"key":"R32-14-20250502","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.transproceed.2008.10.031","article-title":"De novo autoimmune hepatitis after living donor liver transplantation in a 25-day-old newborn baby: a case report.","volume":"41","author":"Oya","year":"2009","journal-title":"Transplant Proc"},{"key":"R33-14-20250502","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.transproceed.2006.03.071","article-title":"De novo autoimmune hepatitis following liver transplantation for primary biliary cirrhosis.","volume":"38","author":"Rodriguez-Diaz","year":"2006","journal-title":"Transplant Proc"},{"key":"R34-14-20250502","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1111\/j.1399-0012.2007.00787.x","article-title":"De novo autoimmune hepatitis following living-donor liver transplantation for primary biliary cirrhosis.","volume":"22","author":"Yoshizawa","year":"2008","journal-title":"Clin Transplant"},{"key":"R35-14-20250502","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1016\/j.transproceed.2010.08.062","article-title":"De novo autoimmune hepatitis with centrilobular necrosis following liver transplantation for primary biliary cirrhosis: a case report.","volume":"42","author":"Zhang","year":"2010","journal-title":"Transplant Proc"},{"key":"R36-14-20250502","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/lt.20706","article-title":"Pegylated interferon-induced immune-mediated hepatitis post-liver transplantation.","volume":"12","author":"Kontorinis","year":"2006","journal-title":"Liver Transpl"},{"key":"R37-14-20250502","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/hep.510250328","article-title":"Banff schema for grading liver allograft rejection: an international consensus document.","volume":"25","year":"1997","journal-title":"Hepatology"},{"key":"R38-14-20250502","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1002\/lt.22302","article-title":"Complement component 4d immunostaining in liver allografts of patients with de novo immune hepatitis.","volume":"17","author":"Aguilera","year":"2011","journal-title":"Liver Transpl"},{"key":"R39-14-20250502","first-page":"783","article-title":"Autoimmune liver diseases in children: what is different from adulthood Best Pract Res Clin G","volume":"25","author":"Mieli-Vergani","year":"2011","journal-title":"astroenterol"},{"key":"R40-14-20250502","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.transproceed.2011.05.028","article-title":"Effectiveness and safety of everolimus in the treatment of autoimmune hepatitis related to antihepatitis C virus therapy after liver transplant: three case reports.","volume":"43","author":"Casanovas","year":"2011","journal-title":"Transplant Proc"},{"key":"R41-14-20250502","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.humpath.2006.08.028","article-title":"Patterns of recurrent hepatitis C after liver transplantation in a recent cohort of patients.","volume":"38","author":"Khettry","year":"2007","journal-title":"Hum Pathol"},{"key":"R42-14-20250502","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/lt.21721","article-title":"Risk factors for developing de novo autoimmune hepatitis associated with antiglutathione S-transferase T1 antibodies after liver transplantation.","volume":"15","author":"Salcedo","year":"2009","journal-title":"Liver Transpl"},{"key":"R43-14-20250502","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1016\/j.transproceed.2011.06.015","article-title":"Everolimus in clinical practice in long-term liver transplantation: an observational study.","volume":"43","author":"Casanovas","year":"2011","journal-title":"Transplant Proc"}],"container-title":["Current Opinion in Organ Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00075200-201206000-00014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T22:04:46Z","timestamp":1746223486000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00075200-201206000-00014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/mot.0b013e3283536622","relation":{},"ISSN":["1087-2418"],"issn-type":[{"value":"1087-2418","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}